Symposium Session: Prebiotics and Gut Microbiota: Establishing a Healthy Trajectory From Early Life to Adulthood
This session will examine the potential for dietary factors including prebiotics to modify the gut microbiota and highlight clinical and public health applications of prebiotics for chronic disease management throughout different life stages. Given that dietary and microbial exposures in early life are known to be highly influential in programming health and chronic disease risk later in life, we will examine recent research looking at the role of prebiotics in pregnancy and infancy/childhood. Recent research on the potential role of prebiotics in managing chronic diseases such as obesity and osteoarthritis will be explored. The presentation will conclude with ways in which health professionals can consider gut microbiota and prebiotics to improve chronic disease risk in public health and clinical settings.
This is not a webinar or course for purchase - this is a module for credit claiming for our 2023 Spring Symposium attendees and cannot be purchased or taken by non-attendees. These sessions are exclusive to our Symposium; however, the topics may be revisited in the future in the form of a webinar or self-study course.
Presented by Raylene Reimer, PhD, RD.
Raylene Reimer, PhD, RD, has the following relevant disclosures to report: she has received research funding and/or speaker honoraria from Beneo, General Mills, and BioRad.
Beneo Institute #21932 is approved by the CDR to offer 1.0 CPEU for this activity.
- 1.00 CDR